Figure 2. Mean plasma concentration of Aprepitant following 125-mg of oral Aprepitant and 115-mg IV Fosaprepitant.
Reproduced from the EMEND_IV product information sheet with permission from Merck Sharp & Dohme Corp.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.